8-K
filed July 31, 2025, 7:59 PM ET
CIK 0001300734
other material
confidence high
sentiment negative
materiality 0.75
Shineco gets Nasdaq stay after Panel denial; lawsuit against Nasdaq filed
SHINECO, INC.
- Nasdaq Panel denied continued listing on July 25; suspension set for July 29.
- Listing Council called review on July 28, staying suspension pending outcome; stock remains listed.
- Company must submit memorandum to Listing Council by August 11, 2025.
- Company and two shareholders sued Nasdaq on July 28 for breach of contract; TRO motion withdrawn as moot.
- Lawsuit remains pending; no assurance of final listing outcome.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001641172-25-021606
- form_type
- 8-K
- ticker
- null
- cik
- 0001300734
- company_name
- SHINECO, INC.
- filed_at
- 2025-07-31T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:43.614637+00:00
- generated_at
- 2026-05-17T22:11:43.583453+00:00
- sec_items
- ["3.01", "8.01"]
- event_type
- other_material
- sentiment
- negative
- materiality_score
- 0.75
- calibrated_materiality_score
- 0.75
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001641172-25-021606
- json_url
- https://secwatch.observer/filing/0001641172-25-021606.json
- markdown_url
- https://secwatch.observer/filing/0001641172-25-021606.md
- text_url
- https://secwatch.observer/filing/0001641172-25-021606.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1300734/000164117225021606/0001641172-25-021606-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1300734/000164117225021606/form8-k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
ISPC
iSpecimen prices $2.5M private placement at $5.12/share; regains Nasdaq minimum bid price compliance
iSpecimen Inc.
May 13, 2026, 5:00 PM ET
other_material
Items 1.01, 3.01, 3.02, 7.01, 8.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 8.01
same event type: other_material
similar materiality
This filing
July 28, 2025, the Company received notice that the Nasdaq Listing and Hearing Review Council (the “Listing Council”), pursuant
to its authority under Nasdaq Listing Rule 5820(b), decided to call this matter for review and to grant a stay of the Panel Decision
pending the outcome of that review, thereby staying the suspension of trading and delisting of the Company’s common stock pending
further review by the Listing Council (the “Listing Council Letter”). Specifically, the Listing Council Letter confirmed
that the Listing Council stayed the effectiveness of the July 25, 2025, Panel Decision p
Comparable filing
minimum $1.00 per share required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum
Bid Price Requirement”) for the prior 30 consecutive business days. On May 12, 2026
Filing page
SEC filing
GNLN
Greenlane regains Nasdaq compliance; BIC limits warrant conversion; board lock-up to April 2027
Greenlane Holdings, Inc.
April 27, 2026, 7:59 PM ET
other_material
Items 3.01, 7.01, 8.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 8.01
same event type: other_material
similar materiality
This filing
July 28, 2025, the Company received notice that the Nasdaq Listing and Hearing Review Council (the “Listing Council”), pursuant
to its authority under Nasdaq Listing Rule 5820(b), decided to call this matter for review and to grant a stay of the Panel Decision
pending the outcome of that review, thereby staying the suspension of trading and delisting of the Company’s common stock pending
further review by the Listing Council (the “Listing Council Letter”). Specifically, the Listing Council Letter confirmed
that the Listing Council stayed the effectiveness of the July 25, 2025, Panel Decision p
Comparable filing
March 25, 2026, Greenlane Holdings, Inc. (the “ Company ”) received a written notice
(the “ Notice ”) from the Nasdaq Listing Qualifications Department of the Nasdaq Stock Market LLC (“ Nasdaq ”)
indicating that Nasdaq s
Filing page
SEC filing
ADTX
Aditxt receives Nasdaq deficiency for negative equity; delisting hearing set for June 11
Aditxt, Inc.
May 29, 2026, 4:21 PM ET
other_material
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: other_material
similar materiality
This filing
July 28, 2025, the Company received notice that the Nasdaq Listing and Hearing Review Council (the “Listing Council”), pursuant
to its authority under Nasdaq Listing Rule 5820(b), decided to call this matter for review and to grant a stay of the Panel Decision
pending the outcome of that review, thereby staying the suspension of trading and delisting of the Company’s common stock pending
further review by the Listing Council (the “Listing Council Letter”). Specifically, the Listing Council Letter confirmed
that the Listing Council stayed the effectiveness of the July 25, 2025, Panel Decision p
Comparable filing
May 27, 2026, Aditxt, Inc. (the “Company”)
received a letter (the “Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market
LLC (“Nasdaq”) notifying the Company that, based on the stockholders’ equity of $(35,174,386) reported in the Company’s
Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”), the Company no longer satisfies the minimum
stockholders’ equity requirement of $2,500,000 for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1)
(the “Stockholders’ Equity Requirement”). The Letter further
Filing page
SEC filing
LIMN
Liminatus Pharma receives Nasdaq delisting notice; appeals filed
Liminatus Pharma, Inc.
May 27, 2026, 4:30 PM ET
other_material
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: other_material
similar materiality
This filing
July 28, 2025, the Company received notice that the Nasdaq Listing and Hearing Review Council (the “Listing Council”), pursuant
to its authority under Nasdaq Listing Rule 5820(b), decided to call this matter for review and to grant a stay of the Panel Decision
pending the outcome of that review, thereby staying the suspension of trading and delisting of the Company’s common stock pending
further review by the Listing Council (the “Listing Council Letter”). Specifically, the Listing Council Letter confirmed
that the Listing Council stayed the effectiveness of the July 25, 2025, Panel Decision p
Comparable filing
May 20, 2026, the Company received a notice
from Nasdaq stating that the Company had not regained compliance with the MVLS Rule and the MVPHS Rule. Accordingly, its securities will
be delisted from The Nasdaq Global Mark
Filing page
SEC filing
TNON
Tenon Medical receives Nasdaq delisting notice for failing minimum stockholders' equity
Tenon Medical, Inc.
May 22, 2026, 5:15 PM ET
other_material
Items 3.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: other_material
similar materiality
This filing
July 28, 2025, the Company received notice that the Nasdaq Listing and Hearing Review Council (the “Listing Council”), pursuant
to its authority under Nasdaq Listing Rule 5820(b), decided to call this matter for review and to grant a stay of the Panel Decision
pending the outcome of that review, thereby staying the suspension of trading and delisting of the Company’s common stock pending
further review by the Listing Council (the “Listing Council Letter”). Specifically, the Listing Council Letter confirmed
that the Listing Council stayed the effectiveness of the July 25, 2025, Panel Decision p
Comparable filing
May 21, 2026, Tenon Medical, Inc. (the “Company”)
received a written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) dated May 21, 2026, notifying
the Company that it is no longer in compliance with the
Filing page
SEC filing
AGAE
AIFA gets Nasdaq delisting notice for late filings; later files FY 2025 10-K
Allied Gaming & Entertainment Inc.
May 21, 2026, 9:40 PM ET
other_material
Items 3.01, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: other_material
similar materiality
This filing
July 28, 2025, the Company received notice that the Nasdaq Listing and Hearing Review Council (the “Listing Council”), pursuant
to its authority under Nasdaq Listing Rule 5820(b), decided to call this matter for review and to grant a stay of the Panel Decision
pending the outcome of that review, thereby staying the suspension of trading and delisting of the Company’s common stock pending
further review by the Listing Council (the “Listing Council Letter”). Specifically, the Listing Council Letter confirmed
that the Listing Council stayed the effectiveness of the July 25, 2025, Panel Decision p
Comparable filing
May 19, 2026, All In FutureTech Alliance,
Inc. (formerly known as Allied Gaming & Entertainment Inc., the “Company”) received a deficiency letter (the “Letter”)
from the Listing Qualifications Department (the “Staff”) of
Filing page
SEC filing
PMI
Picard Medical Q1 revenue up 85% to $1.2M; reports $1.4M negative equity, NYSE listing notices
Picard Medical, Inc.
May 21, 2026, 4:15 PM ET
other_material
Items 2.02, 3.01, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: other_material
similar materiality
This filing
July 28, 2025, the Company received notice that the Nasdaq Listing and Hearing Review Council (the “Listing Council”), pursuant
to its authority under Nasdaq Listing Rule 5820(b), decided to call this matter for review and to grant a stay of the Panel Decision
pending the outcome of that review, thereby staying the suspension of trading and delisting of the Company’s common stock pending
further review by the Listing Council (the “Listing Council Letter”). Specifically, the Listing Council Letter confirmed
that the Listing Council stayed the effectiveness of the July 25, 2025, Panel Decision p
Comparable filing
reviously disclosed, on May
8, 2026, the Company received a notice that it was not in compliance with Section 1003(a)(ii) (the “May 8 Notice,” and together
with the May 15 Notice, the “ Notices ”). In connection with the
Filing page
SEC filing
SNYR
Synergy CHC receives Nasdaq delisting notice for bid price below $1.00
Synergy CHC Corp.
May 18, 2026, 9:01 AM ET
other_material
Items 3.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: other_material
similar materiality
This filing
July 28, 2025, the Company received notice that the Nasdaq Listing and Hearing Review Council (the “Listing Council”), pursuant
to its authority under Nasdaq Listing Rule 5820(b), decided to call this matter for review and to grant a stay of the Panel Decision
pending the outcome of that review, thereby staying the suspension of trading and delisting of the Company’s common stock pending
further review by the Listing Council (the “Listing Council Letter”). Specifically, the Listing Council Letter confirmed
that the Listing Council stayed the effectiveness of the July 25, 2025, Panel Decision p
Comparable filing
May 15, 2026, Synergy CHC Corp. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of
The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based on the closing
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.